diphenylamine has been researched along with Canine Diseases in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (90.91) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, J; Giraudel, JM; King, JN; Lees, P; Pelligand, L; Toutain, PL | 1 |
| Bennett, D; Eckersall, PD; Marchetti, V; McCulloch, E; Rota, A; Sbrana, S; Waterston, M | 1 |
| Fink, M; Giraudel, JM; Gruet, P; Jung, M; King, JN; Letellier, I; Mochel, JP; Peyrou, M | 1 |
| Gulda, D; Lew, M; Szarek, J; Szarek-Bęska, A; Szweda, M | 1 |
| Borer, LR; King, JN; Peel, JE; Seewald, W | 1 |
| Bryan, JN; Eaton, AM; Henry, CJ; Kim, DY; Kumar, SR; Robinson, KL | 1 |
| Choisunirachon, N; Fujita, N; Hanafusa, M; Nakagawa, T; Nakaoka, N; Nishimura, R; Ong, SM; Saeki, K; Watanabe, M; Yoshitake, R | 1 |
| Jung, M; King, JN; Lees, P; Schmid, VB; Seewald, W; Spreng, DE | 1 |
| Gruet, P; King, JN; Seewald, W | 1 |
| Gruet, P; King, JN; Reymond, N; Seewald, W; Speranza, C | 1 |
| Edamura, K; King, JN; Okumura, M; Sakakibara, N; Seewald, W | 1 |
1 review(s) available for diphenylamine and Canine Diseases
| Article | Year |
|---|---|
Pharmacology, safety, efficacy and clinical uses of the COX-2 inhibitor robenacoxib.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cat Diseases; Cats; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diphenylamine; Dog Diseases; Dogs; Phenylacetates | 2022 |
5 trial(s) available for diphenylamine and Canine Diseases
| Article | Year |
|---|---|
Evaluation of the dose-response relationship of oral robenacoxib in urate crystal-induced acute stifle synovitis in dogs.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diphenylamine; Dog Diseases; Dogs; Lameness, Animal; Phenylacetates; Stifle; Synovitis; Uric Acid | 2017 |
Analgesic and anti-inflammatory actions of robenacoxib in acute joint inflammation in dog.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Diphenylamine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Female; Half-Life; Male; Meloxicam; Phenylacetates; Synovitis; Thiazines; Thiazoles; Uric Acid | 2010 |
Evaluation of subcutaneous and oral administration of robenacoxib and meloxicam for the treatment of acute pain and inflammation associated with orthopedic surgery in dogs.
Topics: Administration, Oral; Analgesics; Animals; Diphenylamine; Dog Diseases; Dogs; Female; Inflammation; Infusions, Subcutaneous; Male; Meloxicam; Orthopedic Procedures; Pain, Postoperative; Phenylacetates; Thiazines; Thiazoles | 2011 |
Robenacoxib vs. carprofen for the treatment of canine osteoarthritis; a randomized, noninferiority clinical trial.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Diphenylamine; Dog Diseases; Dogs; Female; Male; Osteoarthritis; Phenylacetates | 2012 |
Comparison of oral robenacoxib and carprofen for the treatment of osteoarthritis in dogs: a randomized clinical trial.
Topics: Administration, Oral; Analysis of Variance; Animals; Carbazoles; Diphenylamine; Dog Diseases; Dogs; Japan; Osteoarthritis; Phenylacetates; Prospective Studies; Statistics, Nonparametric; Treatment Outcome | 2012 |
5 other study(ies) available for diphenylamine and Canine Diseases
| Article | Year |
|---|---|
The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis.
Topics: Animals; C-Reactive Protein; Cyclooxygenase Inhibitors; Diphenylamine; Dog Diseases; Dogs; Female; Lameness, Animal; Male; Osteoarthritis; Phenylacetates; Radiography; Stifle; Synovial Fluid | 2013 |
Population pharmacokinetic analysis of blood concentrations of robenacoxib in dogs with osteoarthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Chronic Disease; Diphenylamine; Dog Diseases; Dogs; Female; Male; Osteoarthritis; Phenylacetates; Sex Factors | 2013 |
Can liquorice extract and herbal solution prevent colonic mucosa damage caused by robenacoxib in dogs?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Colonic Diseases; Diphenylamine; Dog Diseases; Dogs; Female; Glycyrrhiza; Intestinal Mucosa; Male; Phenylacetates; Plant Extracts | 2015 |
Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors.
Topics: Animals; Benzimidazoles; Cell Line, Tumor; Diphenylamine; Dog Diseases; Dogs; Down-Regulation; Flow Cytometry; Immunoblotting; Lymphoma, B-Cell; Mitogen-Activated Protein Kinase Kinases; Polymerase Chain Reaction; Programmed Cell Death 1 Receptor; Sulfonamides | 2017 |
Molecular investigation of the direct anti-tumour effects of nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell lines.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cyclooxygenase Inhibitors; Dinoprostone; Diphenylamine; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Gene Expression Profiling; Neoplasms; Phenylacetates; Piroxicam; Prostaglandin D2 | 2017 |